Richard Batrla

机构：Eisai (United States)

发表论文 54 篇 · 总被引 4556 次 · h-index 23

代表论文

• Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease (2024 · Nature Reviews Neurology · 被引 294)
• Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape (2023 · Neuron · 被引 276)
• An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum (2020 · Alzheimer s & Dementia · 被引 157)
• The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau (2021 · Alzheimer s & Dementia · 被引 137)
• Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer's disease (2024 · Alzheimer s & Dementia · 被引 117)
• Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers (2020 · Neurobiology of Aging · 被引 49)